Orbimed Advisors Trims $125 After Breakout Year in Biotech
A major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
Discover various ways to increase your cash back earnings. Enhance your savings potential with these effective strategies.
24,319 articlesA major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
Jack Schlossberg issues a blunt warning to America’s CEOs: treat culture and AI-driven shifts as core business risks,...
Upstart has been navigating a challenging stretch as the stock declines. This article breaks down whether the drop cr...
Oil surged to $114 intraday earlier this year, forcing a rethink on how investors access crude exposure. Traders now ...
Palantir tumbles about 7% midday as Palo Alto Networks and CrowdStrike hold steadier, raising questions about governm...
The global memory shortage is shaking up pricing and supply chains. This article explains how Apple can actually bene...
Diageo slashed its dividend by half while lowering its sales outlook, highlighting renewed weakness in the U.S. premi...
Two data storage stocks just flashed golden crosses, signaling momentum as AI demand tightens capacity. Here’s what i...
Global CFO appointments cooled in Q1 2026 while retirements surged, spotlighting a shortage of battle-tested cfos and...
New analysis shows the Trump family generated roughly $2.3 billion in pretax crypto income from late 2024 through Apr...
In morning trading, Tesla sinks about 5% while Lucid edges higher and Rivian drifts, signaling a diverging path for t...
AI infrastructure names rebounded on Wednesday, led by Terawulf and IREN as risk appetite returns to tech equities. A...